Company news
Bone Biologics Corp news in 2023
Bone Biologics Corp's news releases, calls and decks from 2023, newest first.
Bone Biologics Announces 1-for-8 Reverse Stock Split
December 17, 2023
Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 20, 2023
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 15, 2023
Bone Biologics Provides Scientific Update on NB1 Bone Graft Device
September 25, 2023
Bone Biologics Prices $5.0 Million Underwritten Public Offering
June 13, 2023
Bone Biologics Effects 1-for-30 Reverse Stock Split
June 5, 2023
Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
April 10, 2023
Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization
January 25, 2023